Clovis Oncology Inc.


BOULDER, Colorado, June 2, 2011 - - PF-01367338 is currently in Phase 1/2 development in combination with chemotherapy in patients with solid tumors - Phase 2 data from IV formulation demonstrate encouraging activity and safety profile - Clovis to assume responsibility for all development and commercial activities worldwide - Pfizer to invest in Clovis Oncology Clovis Oncology, Inc.
Older News
S M T W T F S
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31 1 2 3 4
Copyright© 2011 The Gaea Times